Navigation Links
Notice of Initial Distribution of Net Settlement Funds
Date:6/2/2008

SAN JOSE, Calif., Jun. 2 /PRNewswire/ -- The following release was issued today by Thomas P. DiNapoli, Comptroller of the State of New York, as Trustee of the New York State Common Retirement Fund, the Lead Plaintiff in the In re McKesson HBOC, Inc. Securities Litigation.

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN JOSE DIVISION

In re McKESSON HBOC, INC. (NYSE: MCK) SECURITIES LITIGATION

Master File No. 99-CV-20743 RMW (PVT)

And Related Cases

CLASS ACTION

This Document Relates To: ALL ACTIONS.

TO: (1) ALL PERSONS AND ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED PUBLICLY TRADED SECURITIES OF HBO & COMPANY ("HBOC") DURING THE PERIOD FROM JANUARY 20, 1997 THROUGH AND INCLUDING JANUARY 12, 1999, AND ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED CALL OPTIONS OR SOLD PUT OPTIONS OF HBOC DURING THE PERIOD FROM JANUARY 20, 1997 THROUGH AND INCLUDING APRIL 27, 1999;

(2) ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED PUBLICLY TRADED SECURITIES OR CALL OPTIONS, OR WHO SOLD PUT OPTIONS, OF MCKESSON OR OF MCKESSON HBOC, INC. DURING THE PERIOD FROM OCTOBER 18, 1998 THROUGH AND INCLUDING APRIL 27, 1999; AND

(3) ALL PERSONS OR ENTITIES WHO HELD MCKESSON COMMON STOCK ON NOVEMBER 27, 1998 AND STILL HELD THOSE SHARES ON JANUARY 12, 1999; AND WHO WERE INJURED THEREBY.

Pursuant to the Court's Order dated February 14, 2008, an initial distribution of the Net Settlement Funds in In re McKesson HBOC, Inc. Securities Litigation, Case No. 99-CV-20743 RMW (PVT), recently has been made to all Settlement Class Members who submitted a Claim to the Claims Administrator, Analytics Incorporated, and who did not receive from the Claims Admin
'/>"/>

SOURCE BERNSTEIN LITOWITZ BERGER & GROSSMANN LLP; BARRACK, RODOS& BACINE
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Pharmacyclics Announces It Received Nasdaq Notice of Compliance
2. Signalife Appoints Lee Ehrlichman as Company Director and Operations Director; Additional Notice Received From Amex Regarding Sharholders Equity Deficiency
3. Notice of Time Change for Alexions Presentation at the Bank of America 2008 Health Care Conference
4. Resverlogix Notice of Conference Call & Webcast
5. Notice of conference call and webcast
6. Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimers Disease
7. Tapestry Receives Nasdaq Delisting Notice
8. Genmab A/S - Notice to Convene Annual General Meeting
9. EntreMed Receives Nasdaq Deficiency Notice
10. Vermillion Receives NASDAQ Notice of Non-Compliance
11. Caliper Life Sciences Fourth Quarter 2007 Financial Results Conference Call Notice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013  Cellular Biomedicine Group (OTCQB: CBMG) today ... the total projected enrollment required for its Phase ... efficacy of the medical technology haMPC (Human Adipose-derived ... To date the trial has had no Severe ... I open label clinical research trial for KOA, ...
(Date:5/17/2013)... Calif. , May 17, 2013 /PRNewswire-iReach/ -- ... has been reached with Switzerland ... of anti-infective human monoclonal antibody (mAb) products, and ... human mAb products for treatment of infections by ... Staphylococcus aureus , Pseudomonas aeruginosa , ...
(Date:5/17/2013)... Men’s skin is biologically different than women’s skin,( says skin ... known to react more aggressively when hormones change, and acne ... other acne causing factors like P.acnes bacteria and excess dirt ... unsightly acne scars. Adult acne treatment, Probiotic Action shares new ... to reduce and prevent acne scarring. , In order to ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 RURO ... ezColony version 4.1, a versatile refinement to the ... software solution, improves its advanced methodical management for ... with ezColony 4.1. The network-based platform provides user ... effective research. While continuing to emphasize streamlined tasks, ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2
... FRANCISCO, Calif., March 14 ,Renovis, Inc. (Nasdaq: RNVS ... of drugs for major medical needs in the areas ... fourth quarter and year ended December 31, 2007., ... December 31, 2007 was,$1.3 million and $9.8 million, respectively, ...
... MADISON, N.J., March 14 Quest Diagnostics,Incorporated (NYSE: ... diagnostic,testing, information and services, announced that it is ... Global Healthcare Conference on,Wednesday, March 19, 2008, at ... Diagnostics presentation is scheduled to begin at 9:00 ...
... NuVasive, Inc. (Nasdaq:,NUVA), a medical device company focused on ... announced today,that Kevin O,Boyle, Executive Vice President and Chief ... Eleventh Annual Global,Healthcare Conference at the Loews Miami Beach ... at 10:15 a.m. ET., A live Web cast ...
Cached Biology Technology:Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 2Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 3Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 4Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 5Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 6Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 7Quest Diagnostics to Speak at Lehman Brothers 11th Annual Global Healthcare Conference 2NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 2NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 3
(Date:5/17/2013)... study finds human-caused climate change may have little ... a host of recent studies that predict their ... The findings, which appear in the journal ... survival of a creature thought to be doomed: ... cold-blooded animals, especially forest lizards, will be hard ...
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) Program ... Endocrine Society (ENDO) 95th Annual Meeting in San ... are meant to promote the entry of students, ... mainstream of the basic science community and to ... ENDO 2013 Annual Meeting. , Awards are given ...
(Date:5/16/2013)... scientists have shown a gene involved in neurodegenerative disease ... of the circadian clock. , In a study ... gene, called Ataxin-2, keeps the clock responsible for sleeping ... the rhythm of the fruit fly,s sleep-wake cycle is ... for the fly. , The discovery is particularly ...
Breaking Biology News(10 mins):Climate change may have little impact on tropical lizards 2Gene involved in neurodegeneration keeps clock running 2
... a new technique for the in vivo imaging of ... protein. This imaging technique enables the monitoring of neuronal ... in either a small group of neurons or in ... the development were The Molecular Embryology Unit (CNRS/Institut Pasteur) ...
... de sustancias antagonistas producidas por microorganismos" (Antagonistic substances ... of the University of Granada (Universidad de Granada ... AS-48, which could have a medium-term use as ... that biopreservation is an innovative method in food-preservation ...
... In laboratory tests on mice, researchers found that a ... chemotherapy induced bone loss and helped tumors grow in ... Medicine in St. Louis are recommending increased awareness of ... studied is a growth factor commonly used to help ...
Cached Biology News:Bioluminescence at the service of a novel cerebral imaging technique 2Bioluminescence at the service of a novel cerebral imaging technique 3Researchers from the UGR use a bacterium to obtain biopreservatives from food 2Researchers urge monitoring of bone health during chemotherapy 2Researchers urge monitoring of bone health during chemotherapy 3